Synthetic opioid production in Europe with Paul Griffiths

Synthetic opioid production in Europe with Paul Griffiths

When you think of synthetic opioids, you might picture a distant issue, but for Europe, it's an evolving crisis. In this episode of 'Addiction Audio', Dr. Elle Wadsworth sits down with Paul Griffiths, the Scientific Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), to shed light on the complexities surrounding synthetic opioid production and its impact across the continent.

Paul dives into the differences between lab-made substances and diverted medical drugs, painting a vivid picture of how organized crime influences drug availability and the potential for contamination. They also touch on fentanyl and the looming threat of a heroin shortage due to changes in opium production in Afghanistan. What’s truly eye-opening is how small labs, sometimes as tiny as a kitchen setup, can cause significant spikes in local drug consumption and related deaths.

Paul shares fascinating insights into how researchers track these trends using innovative methods like wastewater analysis. If you're keen to understand the intricate dynamics of Europe's drug markets and the urgent need for better monitoring and response strategies, this episode is a must-listen.